add directory ♦ travel nurse jobs
Today's News:
All Neurology Jobs
Permanent Neurology Job in Portland Oregon with Providence Health & Services
Portland, Oregon -- Providence Health & Services is seeking an excellent Stroke Neurologist to join us in an active neurological practice. Ideally seeking a Neurointensive Care Specialist; Vascular Neurologist
Permanent Neurology Job in Anchorage Alaska with Providence Health & Services
Anchorage, Alaska -- Providence Alaska Medical Center is seeking a behavioral neurologist, psychiatrist or neuropsychiatrist to join our Neuropsychiatry Services Department. Will share duties with another
Permanent Neurology Job in Walla walla Washington with Providence Health & Services
St. Mary Medical Center in Walla Walla, Washington, is seeking an outstanding neurologist specializing in EEG, and EMG to join our top-rated hospital. General practice, shared call in the community is
Archives of Neurology recent issues
NEUROLOGICAL REVIEW: Blood Protein Signature for the Early Diagnosis of Alzheimer Disease
Britschgi, M., Wyss-Coray, T. Mon, 08 Dec 2008 00:00:00 -0000
Alzheimer disease (AD) has become one of the main health concerns for the elderly population in the United States. Current treatments target symptoms only, but several advanced clinical trials are testing new drugs that are potentially disease modifying. Because AD is still difficult to diagnose in its earliest stages and the disease process is estimated to start many years before current clinical diagnosis is made, accurate and simple diagnostic tools are urgently needed. We recently described a blood-based panel of secreted signaling proteins that distinguishes between blinded samples from patients with AD and control subjects with high accuracy. The same proteins also predicted progression to AD in preclinical patients with mild cognitive impairment several years before clinical diagnosis for AD was made. Herein, we describe these findings and discuss the potential for a more general application of our proteomic approach in understanding and diagnosing disease.Published online December 8, 2008 (doi:10.1001/archneurol.2008.530).
ORIGINAL CONTRIBUTION: Heterogeneity in Response to Interferon Beta in Patients With Multiple Sclerosis: A 3-Year Monthly Imaging Study
Chiu, A. W., Richert, N., Ehrmantraut, M., Ohayon, J., Gupta, S., Bomboi, G., Gaindh, D., Cantor, F. K., Frank, J. A., McFarland, H. F., Bagnato, F. Mon, 10 Nov 2008 00:00:00 -0000
Objectives To investigate the heterogeneity in magnetic resonance image (MRI) patterns of response to interferon beta across patients with multiple sclerosis or within an individual patient over time.Design, Setting, and Patients Fifteen patients with relapsing-remitting multiple sclerosis underwent monthly MRIs and clinical examinations (6-month pretherapy phase and 36-month therapy phase) and bimonthly neutralizing antibody tests. On each MRI, the total number of contrast-enhancing lesions was noted. Therapy MRI responders were defined as those with a reduction of 60% or more in the total number of contrast-enhancing lesions during each semester of therapy.Intervention Subcutaneous administration of interferon beta-1b, 250 µg, every other day for 3 years.Main Outcome Measure Reduction in the number of contrast-enhancing lesions.Results Eight patients (53.3%) were MRI responders and 7 (46.7%) were nonresponders. Of those 7, 3 (20.0%) had only an initial optimal reduction of the total number of contrast-enhancing lesions, 2 (13.3%) never reached an optimal response, and 2 (13.3%) had a delayed optimal response. No clear association between neutralizing antibody profile and MRI response was evident.Conclusions Multiple MRI evaluations disclose that approximately only half of the patients treated with interferon beta achieve and maintain a full response to the drug over time, although an additional small number of individuals may still restore an optimal response to the drug after an initial failure.Published online November 10, 2008 (doi:10.1001/archneur.66.1.noc80047).
ABOUT THIS JOURNAL: About This Journal
Mon, 08 Dec 2008 00:00:00 -0000
Subscribe to Clinics RSS feed 
Permanent Neurology Job in Portland Oregon with Providence Health & Services
Portland, Oregon -- Providence Health & Services is seeking an excellent Stroke Neurologist to join us in an active neurological practice. Ideally seeking a Neurointensive Care Specialist; Vascular Neurologist
Permanent Neurology Job in Anchorage Alaska with Providence Health & Services
Anchorage, Alaska -- Providence Alaska Medical Center is seeking a behavioral neurologist, psychiatrist or neuropsychiatrist to join our Neuropsychiatry Services Department. Will share duties with another
Permanent Neurology Job in Walla walla Washington with Providence Health & Services
St. Mary Medical Center in Walla Walla, Washington, is seeking an outstanding neurologist specializing in EEG, and EMG to join our top-rated hospital. General practice, shared call in the community is
Archives of Neurology recent issues
NEUROLOGICAL REVIEW: Blood Protein Signature for the Early Diagnosis of Alzheimer Disease
Britschgi, M., Wyss-Coray, T. Mon, 08 Dec 2008 00:00:00 -0000
Alzheimer disease (AD) has become one of the main health concerns for the elderly population in the United States. Current treatments target symptoms only, but several advanced clinical trials are testing new drugs that are potentially disease modifying. Because AD is still difficult to diagnose in its earliest stages and the disease process is estimated to start many years before current clinical diagnosis is made, accurate and simple diagnostic tools are urgently needed. We recently described a blood-based panel of secreted signaling proteins that distinguishes between blinded samples from patients with AD and control subjects with high accuracy. The same proteins also predicted progression to AD in preclinical patients with mild cognitive impairment several years before clinical diagnosis for AD was made. Herein, we describe these findings and discuss the potential for a more general application of our proteomic approach in understanding and diagnosing disease.Published online December 8, 2008 (doi:10.1001/archneurol.2008.530).
ORIGINAL CONTRIBUTION: Heterogeneity in Response to Interferon Beta in Patients With Multiple Sclerosis: A 3-Year Monthly Imaging Study
Chiu, A. W., Richert, N., Ehrmantraut, M., Ohayon, J., Gupta, S., Bomboi, G., Gaindh, D., Cantor, F. K., Frank, J. A., McFarland, H. F., Bagnato, F. Mon, 10 Nov 2008 00:00:00 -0000
Objectives To investigate the heterogeneity in magnetic resonance image (MRI) patterns of response to interferon beta across patients with multiple sclerosis or within an individual patient over time.Design, Setting, and Patients Fifteen patients with relapsing-remitting multiple sclerosis underwent monthly MRIs and clinical examinations (6-month pretherapy phase and 36-month therapy phase) and bimonthly neutralizing antibody tests. On each MRI, the total number of contrast-enhancing lesions was noted. Therapy MRI responders were defined as those with a reduction of 60% or more in the total number of contrast-enhancing lesions during each semester of therapy.Intervention Subcutaneous administration of interferon beta-1b, 250 µg, every other day for 3 years.Main Outcome Measure Reduction in the number of contrast-enhancing lesions.Results Eight patients (53.3%) were MRI responders and 7 (46.7%) were nonresponders. Of those 7, 3 (20.0%) had only an initial optimal reduction of the total number of contrast-enhancing lesions, 2 (13.3%) never reached an optimal response, and 2 (13.3%) had a delayed optimal response. No clear association between neutralizing antibody profile and MRI response was evident.Conclusions Multiple MRI evaluations disclose that approximately only half of the patients treated with interferon beta achieve and maintain a full response to the drug over time, although an additional small number of individuals may still restore an optimal response to the drug after an initial failure.Published online November 10, 2008 (doi:10.1001/archneur.66.1.noc80047).
ABOUT THIS JOURNAL: About This Journal
Mon, 08 Dec 2008 00:00:00 -0000
Sites:
Blue Bird Circle Clinic for Pediatric Neurology: Texas Children’s Hospital, the largest pediatric hospital in the United States, is a Houston-based, worldwide leader in the diagnosis and treatment of childhood diseases, diabetes, asthma, premature births, and attention-related disorders. Get parent tips, find a doctor, or other information by...Children's Hospital: Neurology: We treat and diagnose nervous system and neuromuscular disorders in infants, children and adolescents.
Children's Hospital: Neurology Services: The
Division of Pediatric Neurology: UCI Medical Center provides advanced healthcare services, including diagnosis and treatment programs for cancer, neurosurgery, heart surgery, pediatrics, orthopaedics and women's health.
Division of Pediatric Neurology: Providing consulting, diagnostic, and treatment services, with clinic details and information on research projects. Associated with the University of Alberta, Canada.
Pasquerilla Healthcare Center: Provides details of specialist clinics for childhood headaches, genetic/behavioral syndromes, autism, and communication disorders. Includes research information and an article about dyslexia. Georgetown University Hospital, Washington, D.C., USA.
Pediatric Epilepsy Program: Part of the Medical University of South Carolina, USA, and offering initial clinical evaluation, follow-up, and neurodiagnostic testing. Provides details of the multi-disciplinary team.
Pediatric Neurology: Pediatric Neurology, a division of the Departments of Pediatrics and Neurology at the Massachusetts General Hospital, represents General Pediatric Neurology, Subspecialty Pediatric Neurology and a broad research base. The clinical staff is comprised of thirteen neurologists. All the staff are exp...
Pediatric Neurology Clinic: Provides evaluation and management of all childhood neurological conditions, and includes a pediatric epilepsy program. Located at Lucile Packard Children's Hospital, Mountain View, California.
Pediatric Neurology Clinics: Our pediatric neurology faculty offer consultation services at the Vanderbilt Children's Hospital and Clinics by evaluating and working with patients and families who are dealing with illnesses, disor...
Pediatric Neurology Division: Offering specialist services for patients with epilepsy, neurofibromatosis and cerebral palsy. Includes contact and staff details. Located at the Washington University, St Louis, Missouri, USA.
Section of Pediatric Neurology: The Section of Pediatric Neurology treats a wide range of diseases from learning and behavior disorders to those requiring critical care.
This directory is based on the Open Directory and may have been modified
